Biovitrum Ab

Pricer Ab

Spotify Ab

Biovitrum Ab (publ)

Biovitrum Am (publ.)

Proximagen Limited

Akinion Pharmaceuticals Ab

Björn M Nilsson

Erik Ringberg

Gary Johansson

Nils Hulth

Markus Thor

Jörgen Jubro

Mattias Jönsson

Johan Oskarsson

Benjamin Pelcman

Patrizia Caldirola

Peter Brandt

Jan Tejbrant

Mats Olof Barvesten

Bengt L Lindqvist

Rune Ringom

Erik Nordling

Andreas Erik Cedborg

Jonas Nilsson

Magnus Cernerud

Katarina Beierlein

Helena Lundström

Kristin Hammer

Johan Angbrant

Vendela Parrow

Birger Sjöberg

Bengt Lindqvist

A system is provided for streaming media content in a vehicle. The system includes a personal media streaming appliance system configured to connect to a media delivery system and receive media content from the media delivery system at least via a cellular network. The personal media streaming appliance system operates to transmit a media signal representative to the received media content to a vehicle media playback system so that the vehicle media playback system operates to play the media content in the vehicle.

Playback control assembly for media playback device

Control button assembly for media playback device

Electronic shelf labeling device

The present invention relates to compounds of formula (I): whereinP, R, W, and Ware as described herein, to pharmaceutical compositions comprising the compounds, to processes for their preparation, as well as to the use of the compounds for the preparation of a medicament against 5-HTreceptor-related disorders.

Benzofuran compounds

The present invention relates to novel compounds of formula (I): 

4-substituted indole and indoline compounds

The invention relates to compounds of the general formula (I): wherein The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder, such as eating disorders, especially obesity, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctions, and urinary disorders The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of formula (I).

Certain arylaliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases

The invention-provides 2, 3-, 4- or 5-substituted-N1-(arylsulfonyl)indole and (heteroaryl)indole compounds of the general formula (I): in which Ar, R, R, Rand Rare as defined in the specification. The compounds bind to the 5-HTreceptor and are useful for the treatment and prophylaxis of disorders mediated by the 5-HTreceptor, such as obesity and CNS disorders.

Compounds, their use and preparation

A compound of the general formula (I): wherein R, R, X, Y and Z are as described in the specification.

Pyrimidine compounds and their use

Compounds of the general formula (I):  Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament for the treatment of 5-HTreceptor-related disorders or medical conditions.

Amino-substituted 1H-pyrazin-2-ones and 1H-quinoxalin-2-ones

Compounds of the general formula (I):  Further included are pharmaceutical compositions comprising the compounds, processes for their preparation, as well as the use of the compounds for the preparation of a medicament which particularly acts on the central nervous system, particularly for use as anti-obesity agents.

Compounds and their use

The invention relates to compounds of the general Formula (I):  The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of Formula (I).

The invention provides 2, 3-, 4- or 5-substituted-N1-(arylsulfonyl)indole and (heteroaryl)indole compounds of the general formula (I): in which Ar, R, R, Rand Rare as defined in the specification. The compounds bind to the 5-HTreceptor and are useful for the treatment and prophylaxis of disorders mediated by the 5-HTreceptor, such as obesity and CNS disorders.

The invention relates to compounds of the general formula (I):wherein The compounds may be prepared by per se conventional methods and can be used for treating a human or animal subject suffering from a serotonin-related disorder, such as eating disorders, especially obesity, memory disorders, schizophrenia, mood disorders, anxiety disorders, pain, sexual dysfunctions, and urinary disorders. The invention also relates to such use as well as to pharmaceutical compositions comprising a compound of formula (I).

Growing community of inventors

Stockholm, Sweden

Björn M Nilsson